Severe group A streptococcal infection and a pulmonary hemorrhage

References

• Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin. Infect. Dis. 1992; 14: 298–307.
   PubMed Web of Science ®Google Scholar
• Hodge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of toxic shock-like syndrome: a retro-spective population based study. JAMA 1993: 269: 384–389.
   PubMed Web of Science ®Google Scholar
• O'Brein KL, Levine OS, Schwartz B. The changing epidemi-ology of group A streptococcus infections. Semin. Pediatr. Infect. Dis. 1997; 8: 1–8.
   Google Scholar
• Duff BA, Denny FW, Kiska DL, et al. Invasive group A streptococcal disease in children. Clin. Pediatr. 1999; 38: 417–423.
   PubMed Web of Science ®Google Scholar
• Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg. Infect. 1995; 1: 69–78.
   PubMed Web of Science ®Google Scholar
• Demers B, Simor AE, Velland H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 1993; 16: 792–800.
   PubMed Web of Science ®Google Scholar
• Davies HD, Matlow A, Schriver SR, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared to adults. Pediatr. Infect. Dis. J. 1994; 13: 49–56.
   PubMed Web of Science ®Google Scholar
• Ooe K, Nakada H, Udagawa H, et al. Severe pulmonary hemorrhage in patients with serious group A streptococcal infections: report of two cases. Clin. Infect. Dis. 1999; 28: 1317–1319.
   PubMed Web of Science ®Google Scholar
• Gilboa N, McIntire S, Hopp L, et al. Acute noncrescentric poststreptococcal glomerulonephritis presenting with a pulmonary hemorrhage. Pediatr. Nephrol. 1993; 7: 147–150.
   PubMed Web of Science ®Google Scholar
• Chugh KS, Gupta VK, Singhal PC, et al. Case report: poststreptococcal crescentric glomerulonephritis and pul-monary hemorrhage simulating Goodpasture‘s syndrome. Ann. Allergy. 1981; 47: 104–106.
   PubMedGoogle Scholar
• Lamothe F, D'Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: Case report and review. Clin. Infect. Dis. 1995; 21: 1469–1470.
   PubMed Web of Science ®Google Scholar
• Kaul R, McGeer A, Norrby-Telgund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syn-drome- a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 1999; 28: 800–807.
   Google Scholar
• Dick GF and Dick GH. Therapeutic results with concen-trated scarlet fever antitoxin. JAMA 1925; 84: 803.
   Google Scholar
• Norrby-Teglund A, Kaul R, Low DE, Mcgreer A, Kobt M. Intravenous immunoglobulin and superantigen-neutraliz-ing antibody in streptococcal toxic shock patients [abstract no. LM67]In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995
   Google Scholar
• Norrby-Teglund A, Kaul R, Low DE. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine pro-duction. J. Immunol. 1996; 156: 3057–3064.
   Google Scholar
• Skimozato T, Iwata M, Tamura N. Suppression of tumor necrosis factor alpha production by a human immunoglobu-lin preparation for intravenous use. Infect. Immun. 1990; 58: 1384–1390.
   Google Scholar
• Honore P, Jamez J. Streptococcus group A toxic shock. Beneficial effect of high flow hemofiltration of short dura-tion. Ann. Fr. Anesth. Reanim. 1998; 17: 430–432.
   PubMed Web of Science ®Google Scholar
• Wiles CE, Reynold HN, Bar-Lavie Y. Flush resuscitation for group A streptococcal toxic shock: a possible role for renal replacement therapy and plasmapharesis. Md Med. J. 1998; 47: 188–190.
   Google Scholar